Method of treating neoplastic disease in a human or animal patient
US7939109B1 · kind B1 · utility
0Cited by
10References
15Claims
0Family size
Inventor
Key dates
| Filing date | Oct 2, 2000 |
| Grant date | May 10, 2011 |
| Priority date | — |
| Expiry date | Jun 10, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating neoplastic disease in a human or animal patient is provided comprising administering to the patient an anti-neoplastic effective amount of a composition comprising as the sole pharmaceutically active components (a) copper gluconate or copper orotate; (b) sodium salicylate; (c) vitamin C; (d) manganese gluconate or manganese orotate; and optionally one or more of (e) iron gluconate or iron orotate; (f) sublimed sulphur; and (g) zinc gluconate or zinc orotate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.